Figure 3.
Rg and SASA graphs for the studied protein–ligand complexes with (A,C) for 2-EGFR, 286-EGFR, 291-EGFR, and Erlotinib-EGFR; (B,D) for 2-VEGFR2, 286-VEGFR2, 291-VEGFR2, and Sorafenib-VEGFR2.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.